Cardiovascular risk and comorbidities in patients with rosacea: A systematic review and meta-analysis

Research output: Contribution to journalArticlepeer-review

Abstract

The association between rosacea and cardiovascular disease remains controversial. A systematic review and meta-analysis of the literature, from inception to 15 February 2020, was performed to compare cardiovascular risk and comorbidities in individuals with and without rosacea. Twelve studies, involving 40,752 patients with rosacea, were included. Compared with con-trols, patients with rosacea had higher systolic blood pressure (standardized mean difference (SMD) 0.293, 95% confidence interval (CI) 0.054–0.532), diastolic blood pressure (SMD 0.309, 95% CI 0.003–0.615), to-tal cholesterol (SMD 1.147, 95% CI 0.309–1.984), low-density lipoprotein (SMD 0.792, 95% CI 0.174–1.409), C-reactive protein (SMD 0.26, 95% CI 0.099–0.421), greater epicardial fat thickness (SMD 1.945, 95% CI 1.595–2.296), and higher incidence of hypertension (odds ratio (OR) 1.204, 95% CI 1.097–1.332) and insulin resistance (OR 2.338, 95% CI 1.187–4.605). This study reveals that patients with rosacea are predis-posed to increased subclinical cardiovascular risk.

Original languageEnglish
Article numberadv00300
Pages (from-to)1-7
Number of pages7
JournalActa Dermato-Venereologica
Volume100
Issue number17
DOIs
Publication statusPublished - 2020

Keywords

  • Cardiovascular disease
  • Dyslipidaemia
  • Hyperten-sion
  • Meta-analysis
  • Risk factor
  • Rosacea
  • Systematic review

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Cardiovascular risk and comorbidities in patients with rosacea: A systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this